Management of basal cell carcinoma by surveyed dermatologists in Scotland

Clinical and Experimental Dermatology

Volumn 31, Issue 5, 2006, Pages 648-652

  Gudi, V ^a   Ormerod, A D ^a   Dawn, G ^b   Green, C ^c   MacKie, R M ^d   Douglas, W S ^b   Gupta, G ^b  

^a ABERDEEN ROYAL INFIRMARY   (United Kingdom)

^b MONKLANDS HOSPITAL   (United Kingdom)

^c NINEWELLS HOSPITAL   (United Kingdom)

^d WESTERN INFIRMARY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

FLUOROURACIL;

ADULT; AGED; BASAL CELL CARCINOMA; BIOPSY; CANCER RADIOTHERAPY; CANCER SURGERY; CAUTERIZATION; CLINICAL ASSESSMENT; CORRELATION ANALYSIS; CRYOTHERAPY; CURETTAGE; FACE TUMOR; FEMALE; HEAD AND NECK TUMOR; HISTOLOGY; HOSPITAL ADMISSION; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICAL AUDIT; PATIENT REFERRAL; PHOTODYNAMIC THERAPY; PRACTICE GUIDELINE; PRIORITY JOURNAL; REVIEW; UNITED KINGDOM;

ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, BASAL CELL; COHORT STUDIES; FEMALE; HUMANS; MALE; MIDDLE AGED; PHYSICIAN'S PRACTICE PATTERNS; PRACTICE GUIDELINES; PRACTICE GUIDELINES AS TOPIC; SCOTLAND; SKIN NEOPLASMS; WAITING LISTS;

EID: 33746110720     PISSN: 03076938     EISSN: 13652230     Source Type: Journal    
DOI: 10.1111/j.1365-2230.2006.02199.x     Document Type: Review

References (18)

1. Miller SJ. Etiology and pathogenesis of basal cell carcinoma. Clin Dermatol 1995; 13: 527-36.
2. Lo JS, Snow SN, Reizner GT et al. Metastatic basal cell carcinoma: report of twelve cases with a review of the literature. J Am Acad Dermatol 1991; 24: 715-19.
3. Holme SA, Malinovszky K, Roberts DL. Changing trends in non-melanoma skin cancer in South Wales, 1988-98. Br J Dermatol 2000; 143: 1224-9.
4. de Vries E, Louwman M, Bastiaens M et al. Rapid and continuous increases in incidence rates of basal cell carcinoma in the southeast Netherlands since 1973. J Invest Dermatol 2004; 123: 634-8.
5. Goodwin RG, Holme SA, Roberts DL. Variations in registration of skin cancer in the United Kingdom. Clin Exp Dermatol 2004; 29: 328-30.
6. McLoone NM, Middleton RJ, Gavin AT et al. Audit of basal cell carcinoma: registration practice. Br J Dermatol 2003; 148: 371.
7. Telfer NR, Colver GB, Bowers PW. Guidelines for the management of basal cell carcinoma. British Association of Dermatologists. Br J Dermatol 1999; 141: 415-23.
8. Lucke TW, Hole DJ, Mackie RM. An audit of the completeness of non-melanoma skin cancer registration in Greater Glasgow. Br J Dermatol 1997; 137: 761-3.
9. Har-Shai Y, Hai N, Taran A et al. Sensitivity and positive predictive values of presurgical clinical diagnosis of excised benign and malignant skin tumors: a prospective study of 835 lesions in 778 patients. Plast Reconstr Surg 2001; 108: 1982-9.
10. Hallock GG, Lutz DA. Prospective study of the accuracy of the surgeon's diagnosis in 2000 excised skin tumors. Plast Reconstr Surg 1998; 101: 1255-61.
11. Motley RJ, Gould DJ, Douglas WS et al. Treatment of basal cell carcinoma by dermatologists in the United Kingdom. British Association of Dermatologists Audit Subcommittee and the British Society for Dermatological Surgery. Br J Dermatol 1995; 132: 437-40.
12. Kirkup ME, De Berker DA. Clinical measurement of dimensions of basal cell carcinoma: effect of waiting for elective surgery. Br J Dermatol 1999; 141: 876-9.
13. Wong CS, Strange RC, Lear JT. Basal cell carcinoma. BMJ 2003; 327: 794-8.
14. McCormack CJ, Kelly JW, Dorevitch AP. Differences in age and body site distribution of the histological subtypes of basal cell carcinoma. A possible indicator of differing causes. Arch Dermatol 1997; 133: 593-6.
15. Bath-Hextall F, Bong J, Perkins W et al. Interventions for basal cell carcinoma of the skin: systematic review. BMJ 2004; 329: 705.
16. Royal College of Pathologists. Standards and minimum datasets for reporting cancers. Minimum dataset for the histopathological reporting of common skin cancers, February 2002. Available at: http://www. rcpath.org.uk/resources/ pdf/skincancers2802.pdf (accessed June 2005).
17. Morton CA, Brown SB, Collins S et al. Guidelines for topical photodynamic therapy: report of a workshop of the British Photodermatology Group. Br J Dermatol 2002; 146: 552-67.
18. Schulze HJ, Cribier B, Requena L et al. Imiquimod 5% cream for the treatment of superficial basal cell carcinoma: results from a randomized vehicle-controlled phase III study in Europe. Br J Dermatol 2005; 152: 939-47.